Wozniak AJ - Search Results

1

A phase 1 trial of XK469: toxicity profile of a selective topoisomerase IIbeta inhibitor.

Alousi AM, Boinpally R, Wiegand R, Parchment R, Gadgeel S, Heilbrun LK, Wozniak AJ, DeLuca P, LoRusso PM. Alousi AM, et al. Among authors: wozniak aj. Invest New Drugs. 2007 Apr;25(2):147-54. doi: 10.1007/s10637-006-9024-5. Epub 2006 Nov 11. Invest New Drugs. 2007. PMID: 17103044 Clinical Trial.

2

Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks.

Foster BJ, LoRusso PM, Poplin E, Zalupski M, Valdivieso M, Wozniak A, Flaherty L, Kasunic DA, Earhart RH, Baker LH. Foster BJ, et al. Invest New Drugs. 1996;13(4):321-6. doi: 10.1007/BF00873138. Invest New Drugs. 1996. PMID: 8824350 Clinical Trial.

3

Chronic oral administration of CI-994: a phase 1 study.

Prakash S, Foster BJ, Meyer M, Wozniak A, Heilbrun LK, Flaherty L, Zalupski M, Radulovic L, Valdivieso M, LoRusso PM. Prakash S, et al. Invest New Drugs. 2001;19(1):1-11. doi: 10.1023/a:1006489328324. Invest New Drugs. 2001. PMID: 11291827 Clinical Trial.

4

A phase I clinical trial of spicamycin derivative KRN5500 (NSC 650426) using a phase I accelerated titration "2B" design.

Gadgeel SM, Boinpally RR, Heilbrun LK, Wozniak A, Jain V, Redman B, Zalupski M, Wiegand R, Parchment R, LoRusso PM. Gadgeel SM, et al. Invest New Drugs. 2003 Feb;21(1):63-74. doi: 10.1023/a:1022972427532. Invest New Drugs. 2003. PMID: 12795531 Free article. Clinical Trial.

5

Phase I pharmacokinetic study of the novel antitumor agent SR233377.

LoRusso PM, Foster BJ, Wozniak A, Heilbrun LK, McCormick JI, Ruble PE, Graham MA, Purvis J, Rake J, Drozd M, Lockwood GF, Corbett TH. LoRusso PM, et al. Clin Cancer Res. 2000 Aug;6(8):3088-94. Clin Cancer Res. 2000. PMID: 10955788 Clinical Trial.

6

5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer.

Flaherty L, Wozniak A, Redman B, Kraut M, Martino S, Heilbrun L, Valdivieso M. Flaherty L, et al. Cancer. 1991 Sep 1;68(5):944-7. doi: 10.1002/1097-0142(19910901)68:5<944::aid-cncr2820680506>3.0.co;2-g. Cancer. 1991. PMID: 1655218 Clinical Trial.

7

Neurotoxicity of antineoplastic agents.

Hussain M, Wozniak AJ, Edelstein MB. Hussain M, et al. Among authors: wozniak aj. Crit Rev Oncol Hematol. 1993 Feb;14(1):61-75. doi: 10.1016/1040-8428(93)90006-p. Crit Rev Oncol Hematol. 1993. PMID: 8373541 Review.

8

Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.

Corbett TH, Bissery MC, Wozniak A, Plowman J, Polin L, Tapazoglou E, Dieckman J, Valeriote F. Corbett TH, et al. Invest New Drugs. 1986;4(3):207-20. doi: 10.1007/BF00179586. Invest New Drugs. 1986. PMID: 3546183

9

Anticoagulation therapy for radiation-induced myelopathy.

Liu CY, Yim BT, Wozniak AJ. Liu CY, et al. Among authors: wozniak aj. Ann Pharmacother. 2001 Feb;35(2):188-91. doi: 10.1345/aph.10168. Ann Pharmacother. 2001. PMID: 11215838

10

Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer.

Hsu R, Chen D, Xia B, Feldman R, Cozen W, Raez LE, Borghaei H, Kim C, Nagasaka M, Mamdani H, Vanderwalde AM, Lopes G, Socinski MA, Wozniak AJ, Spira AI, Liu SV, Nieva JJ. Hsu R, et al. Among authors: wozniak aj. Front Oncol. 2023 Aug 28;13:1215524. doi: 10.3389/fonc.2023.1215524. eCollection 2023. Front Oncol. 2023. PMID: 37700839 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page